Clinical Trial Details

Trial ID: L0919
Source ID: IRCT201206094105N8
Associated Drug: Coenzyme Q10
Title: The effect of coenzyme Q10 on serum concentrations of adipokines and Malondialdehyde in non-alcoholic fatty liver disease
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-alcoholic fatty liver disease. <br>Other diseases of liver;Other diseases of liver
Interventions: Intervention 1: One 100 milligram capsule each day for 4 weeks. Intervention 2: One capsule containing starch each day for 4 weeks.;Treatment - Drugs;Placebo;One 100 milligram capsule each day for 4 weeks;One capsule containing starch each day for 4 weeks
Outcome Measures: Chemerin. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: ELIZA.;Vaspin. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: ELIZA.;Malondialdehyde. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Spectrophotometry.Food intake. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: dietary record questionnaire.;Body Mass Index. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Scales and meters.
Sponsor/Collaborators: Vice chancellor for Research, Tabriz University of Medical Sciences
Gender: All
Age: 20 years65 years
Phases: Phase 2
Enrollment: 44
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 15/06/2013
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/4305